Sumatriptan and Heavy or prolong menstrual bleeding - a phase IV clinical study of FDA data
Summary:
Heavy or prolong menstrual bleeding is reported as a side effect among people who take Sumatriptan (sumatriptan succinate), especially for people who are 20-29 old, also take Mirena, and have Birth control.
The phase IV clinical study analyzes which people have Heavy or prolong menstrual bleeding when taking Sumatriptan. It is created by eHealthMe based on reports of 17,179 people who have side effects when taking Sumatriptan from the FDA, and is updated regularly.
What is Sumatriptan?
Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.
What is Heavy or prolong menstrual bleeding?
Heavy or prolong menstrual bleeding is found to be associated with 745 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Heavy or prolong menstrual bleeding.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17,179 people reported to have side effects when taking Sumatriptan.
Among them, 11 people (0.06%) have Heavy or prolong menstrual bleeding.

Among these 11 people:
What is the age of people who have Heavy or prolong menstrual bleeding when taking Sumatriptan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 63.64 %
- 30-39: 9.09 %
- 40-49: 18.18 %
- 50-59: 9.09 %
- 60+: 0.0 %
What are other drugs people take besides Sumatriptan? *
- Mirena: 4 people, 36.36%
- Naproxen: 3 people, 27.27%
- Nuvaring: 3 people, 27.27%
- Clopidogrel: 3 people, 27.27%
- Aspirin: 3 people, 27.27%
- Prozac: 2 people, 18.18%
- Lamictal: 2 people, 18.18%
- Depo-Provera: 2 people, 18.18%
- Cymbalta: 2 people, 18.18%
- Nexium: 2 people, 18.18%
What are other side effects people have besides Heavy or prolong menstrual bleeding? *
- Fatigue (feeling of tiredness): 5 people, 45.45%
- Vaginal Discharge: 5 people, 45.45%
- Abdominal Distension: 4 people, 36.36%
- Uterine Haemorrhage (uterine bleeding): 4 people, 36.36%
- Abdominal Pain: 4 people, 36.36%
- Drug Ineffective: 4 people, 36.36%
- Vaginal Bleeding: 4 people, 36.36%
- Urinary Tract Infection: 4 people, 36.36%
- Retroperitoneal Haemorrhage (bleeding between the peritoneum and the posterior abdominal wall): 3 people, 27.27%
- Nausea (feeling of having an urge to vomit): 3 people, 27.27%
What are the existing conditions these people have? *
- Birth Control: 6 people, 54.55%
- Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 27.27%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 27.27%
- Pseudotumor Cerebri (increased pressure within the brain in the absence of a tumour): 2 people, 18.18%
- Impaired Gastric Emptying: 2 people, 18.18%
- Borderline Personality Disorder: 2 people, 18.18%
- Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery): 1 person, 9.09%
- Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
- Gait Disturbance: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Sumatriptan and have Heavy or prolong menstrual bleeding?
- Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sumatriptan:
- Sumatriptan (18,159 reports)
Heavy or prolong menstrual bleeding treatments and more:
- Heavy or prolong menstrual bleeding (38,063 reports)
How severe was Heavy or prolong menstrual bleeding and when was it recovered:
Expand to all the drugs that have ingredients of sumatriptan succinate:
- Heavy or prolong menstrual bleeding and drugs with ingredients of sumatriptan succinate (51 reports)
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sumatriptan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Heavy or prolong menstrual bleeding:
- Heavy or prolong menstrual bleeding (745 drugs)
Browse all the conditions that are associated with Heavy or prolong menstrual bleeding:
- Heavy or prolong menstrual bleeding (1,264 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan) and Sumatriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nipride cause Renal Impairment? - 2 seconds ago
- Gabapentin and Lantus drug interactions for men aged 50-59 - 4 seconds ago
- Drug interactions of Formoterol Fumarate and Hydramine - 21 seconds ago
- Could Hydrodiuril cause Paroxysmal Supraventricular Tachycardia? - 21 seconds ago
- Could Coq cause Coronary Heart Disease? - 23 seconds ago
- Symmetrel and Renal Failure Acute for Men aged 60+ - 30 seconds ago
- Symmetrel and Renal Failure for Men aged 60+ - 30 seconds ago
- Symmetrel and Kidney Failure for Men aged 60+ - 30 seconds ago
- Symmetrel and Arf for Men aged 60+ - 31 seconds ago
- Symmetrel and Acute Kidney Failure for Men aged 60+ - 31 seconds ago